# Exenatide for idiopathic intracranial hypertension trial

Source: https://pepvault.app/research/exenatide-mitchell-2023

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [Exenatide](https://pepvault.app/research#exenatide)

Randomized trial · people

# Exenatide: lower intracranial pressure in IIH over 12 weeks

Checked against the paper November 2026 Randomized trial [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

In a small early trial, exenatide lowered skull pressure in women with IIH within hours, and the drop held through 12 weeks.

- **Kind:** Randomized trial
- **Studied in:** People
- **Number studied:** 16
- **Published:** 2023
- **Journal:** Brain

## What they tested

The team tested whether exenatide lowers pressure inside the skull in women with idiopathic intracranial hypertension (IIH, raised skull pressure with no known cause).

## How the study was done

A randomized, placebo-controlled, double-blind trial in 16 adult women with active IIH, defined as pressure above 25 cmCSF (a unit of skull pressure) plus papilledema (swelling at the back of the eye), given exenatide or placebo (a dummy shot) under the skin. Implanted sensors tracked skull pressure over time, and 15 women finished the 12-week study.

<!--promo-->

PepVault for iPhone

## Taking exenatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

At the start, the women averaged 28 ± 9 years of age, a body mass index of 38.1 ± 6.2 kg/m2 and a skull pressure of 30.6 ± 5.1 cmCSF. Exenatide lowered skull pressure by -5.7 ± 2.9 cmCSF at 2.5 hours (P = 0.048), -6.4 ± 2.9 cmCSF at 24 hours (P = 0.030) and -5.6 ± 3.0 cmCSF at 12 weeks (P = 0.058). The trial set its threshold for a significant result at a P value under 0.1, chosen before it began. No serious safety signals were seen.

## What it doesn’t show

This was a very small trial of 16 women, 15 of whom finished, and it lasted 12 weeks. It included only adult women with active IIH, and the team saw the results as a reason to move on to a phase 3 trial.

## The paper

Mitchell et al. The effect of GLP-1RA exenatide on idiopathic intracranial hypertension: a randomized clinical trial. Brain. 2023.

- [PubMed (PMID 36907221)](https://pubmed.ncbi.nlm.nih.gov/36907221/)
- [The paper (DOI 10.1093/brain/awad003)](https://doi.org/10.1093/brain/awad003)

## The compound

- [Exenatide: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/exenatide)
- [Exenatide dose guide](https://pepvault.app/lab/dosage/exenatide)

## With this study

### Exenatide

- [Exenatide: the full reference](https://pepvault.app/peptides/exenatide)
- [Exenatide dose guide](https://pepvault.app/lab/dosage/exenatide)

### Studies

- [Exenatide: no cognitive benefit in mild cognitive impairment](https://pepvault.app/research/exenatide-dei-cas-2024)
- [Exenatide did not cut heavy drinking days in alcohol use disorder](https://pepvault.app/research/exenatide-klausen-2022)
- [All 8 studies](https://pepvault.app/research#exenatide)

### Compared with

- [Semaglutide vs Exenatide](https://pepvault.app/peptides/compare/semaglutide-vs-exenatide)
- [Liraglutide vs Exenatide](https://pepvault.app/peptides/compare/liraglutide-vs-exenatide)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Unit (on a syringe)](https://pepvault.app/glossary/syringe-units)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Double-blind](https://pepvault.app/glossary/double-blind)
- [Body mass index (BMI)](https://pepvault.app/glossary/bmi)

## More studies on Exenatide

- [Exenatide: no cognitive benefit in mild cognitive impairment](https://pepvault.app/research/exenatide-dei-cas-2024) Randomized trial · people · 2024
- [Exenatide did not cut heavy drinking days in alcohol use disorder](https://pepvault.app/research/exenatide-klausen-2022) Randomized trial · people · 2022
- [Exenatide: 29.2% spontaneous pregnancy vs 14.7% on metformin in PCOS](https://pepvault.app/research/exenatide-li-2022) Randomized trial · people · 2022
- [Exenatide plus dapagliflozin: UACR fell 39.6% vs 11.0% on placebo](https://pepvault.app/research/exenatide-decrease-2021) Randomized trial · people · 2021
- [Exenatide, alone or with dapagliflozin, improved blood sugar in PCOS](https://pepvault.app/research/exenatide-elkind-hirsch-2021) Randomized trial · people · 2021
- [Exenatide ER: 0.9% HbA1c drop vs 1.5% with semaglutide in SUSTAIN 3](https://pepvault.app/research/exenatide-sustain-3-2018) Randomized trial · people · 2018
- [Every study on Exenatide](https://pepvault.app/research#exenatide)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking exenatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking exenatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### Exenatide

- [Exenatide: the full reference](https://pepvault.app/peptides/exenatide)
- [Exenatide dose guide](https://pepvault.app/lab/dosage/exenatide)

### Studies

- [Exenatide: no cognitive benefit in mild cognitive impairment](https://pepvault.app/research/exenatide-dei-cas-2024)
- [Exenatide did not cut heavy drinking days in alcohol use disorder](https://pepvault.app/research/exenatide-klausen-2022)
- [All 8 studies](https://pepvault.app/research#exenatide)

### Compared with

- [Semaglutide vs Exenatide](https://pepvault.app/peptides/compare/semaglutide-vs-exenatide)
- [Liraglutide vs Exenatide](https://pepvault.app/peptides/compare/liraglutide-vs-exenatide)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Unit (on a syringe)](https://pepvault.app/glossary/syringe-units)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Double-blind](https://pepvault.app/glossary/double-blind)
- [Body mass index (BMI)](https://pepvault.app/glossary/bmi)

<!--promo-->

PepVault for iPhone

## Taking exenatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on Exenatide](https://pepvault.app/research#exenatide)

## The library

- [Exenatide](https://pepvault.app/peptides/exenatide)
- [Exenatide dose guide](https://pepvault.app/lab/dosage/exenatide)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
